3D-Printed Heart Model Beats Like a Real Heart

Researchers at the University of Washington in Seattle have successfully created a 3D-printed heart model that not only replicates the anatomical structure of a human heart but also demonstrates rhythmic contractions resembling a real heartbeat, marking a significant advancement in biomedical engineering and cardiac simulation technology.

The model, developed using a specialized bio-ink composed of human-derived extracellular matrix proteins and living cardiomyocytes, was printed layer by layer to mimic the complex geometry of the left ventricle. When stimulated with electrical impulses, the printed tissue exhibited synchronized contractions that propagated in a wave-like pattern similar to that observed in native heart muscle, according to findings published in the journal Advanced Functional Materials on April 15, 2026.

Lead researcher Dr. Jennifer Sato, associate professor of bioengineering at the University of Washington, explained that the goal was not to create a transplantable organ but to develop a physiologically accurate platform for studying heart disease, testing drug responses and modeling arrhythmias in a controlled laboratory setting. “We wanted something that doesn’t just look like a heart but behaves like one under physiological conditions,” Dr. Sato said in a university press release. “This model allows us to observe how electrical signals trigger mechanical movement in real time, which is critical for understanding conditions like heart failure or ventricular tachycardia.”

The printing process utilized a modified extrusion-based 3D bioprinter capable of maintaining cell viability during fabrication. The bio-ink formulation was optimized to support cell alignment and electrical coupling, enabling the cardiomyocytes to synchronize their beating after approximately seven days of maturation in a nutrient-rich culture medium. Calcium imaging confirmed that calcium flux — a key indicator of cellular excitation-contraction coupling — occurred in a coordinated manner across the tissue construct.

“The fact that we can see coordinated calcium transients leading to measurable contractile force is a major step forward. It means we’re not just seeing spontaneous twitching — we’re seeing physiology.”

Dr. Jennifer Sato, University of Washington

The model’s contractile force was measured using a flexible microelectrode array embedded beneath the printed tissue, which recorded displacement consistent with active systolic shortening. While the generated force was approximately 20% of that produced by adult human ventricular tissue, researchers noted that the model’s responsiveness to pharmacological agents — such as isoproterenol, which increased contraction rate, and blebbistatin, which inhibited myosin activity — closely mirrored expected physiological responses.

These results suggest the model could serve as a valuable tool for preclinical drug screening, particularly for cardiotoxicity testing. Current methods often rely on animal models or two-dimensional cell cultures, which fail to fully recapitulate the three-dimensional architecture and mechanical environment of the heart. The UW team’s approach bridges this gap by providing a more biomimetic system that integrates structure, electrical activity, and mechanical function.

Dr. Elena Ruiz, a cardiovascular scientist at the Fred Hutchinson Cancer Center who was not involved in the study, commented on the potential implications: “Having a living, beating human heart model that we can manipulate and image in real time opens new possibilities for understanding how genetic mutations or environmental toxins affect cardiac function. It’s a powerful complement to existing platforms like organ-on-a-chip technologies.”

The research team acknowledged limitations, including the model’s current lack of vascularization, which restricts its thickness and long-term viability. Without an integrated blood vessel network, the construct remains dependent on diffusion for nutrient delivery, limiting its use to thin tissue layers. Future work will focus on incorporating perfusable channels to support thicker, more complex tissues that better emulate the full ventricular wall.

the model currently uses cardiomyocytes derived from induced pluripotent stem cells (iPSCs) sourced from a single donor line, which may not reflect the genetic diversity seen in human populations. Expanding the use of multiple iPSC lines could enhance the model’s utility for studying population-level variations in drug response and disease susceptibility.

The project was supported by grants from the National Institutes of Health (NIH) and the Washington Research Foundation. No conflicts of interest were reported by the authors. The study’s data and methods have been made available through the university’s digital repository to support reproducibility and further research by other scientific teams.

While the 3D-printed beating heart model is not intended for clinical implantation, its development represents a meaningful step toward creating more accurate, human-relevant systems for cardiac research. By combining advances in bioprinting, stem cell technology, and tissue engineering, scientists are moving closer to platforms that can reliably simulate human heart function — potentially reducing reliance on animal testing and accelerating the development of safer cardiovascular therapies.